Precision medicine has transformed cancer care by personalizing treatment based on the genomic profile of a patient’s cancer. However, challenges remain in the widespread adoption of genomic sequencing, limiting patient access to targeted therapies. Studies show that many patients do not receive precision oncology due to barriers in obtaining biomarker test results and disparities in biopsy referral. Standardizing protocols for biospecimen handling, implementing liquid biopsy assays, and educating healthcare professionals and patients are essential steps to improving precision oncology implementation. Collaboration among stakeholders is crucial to bridging the gap between research and practice in advancing precision oncology.
Source link
Closing the Gap: Advancing Precision Oncology Through Education and Collaboration
